Development of standard clinical endpoints for use in dengue interventional trials
Dengue is a major public health problem worldwide. Although several drug candidates have been evaluated in randomized controlled trials, none has been effective and at present, early recognition of severe dengue and timely supportive care are used to reduce mortality. While the first dengue vaccine...
Main Authors: | Tomashek, K, Wills, B, See Lum, L, Thomas, L, Durbin, A, Leo, Y, De Bosch, N, Rojas, E, Hendrickx, K, Erpicum, M, Agulto, L, Jaenisch, T, Tissera, H, Suntarattiwong, P, Collers, B, Wallace, D, Schmidt, A, Precioso, A, Narvaez, F, Thomas, S, Edelman, R, Siqueira, J, Cassetti, M, Dempsey, W, Gubler, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2018
|
Similar Items
-
Development of standard clinical endpoints for use in dengue interventional trials
by: Tomashek, Kay M., et al.
Published: (2018) -
Severe dengue categories as research endpoints—results from a prospective observational study in hospitalised dengue patients
by: Rosenberger, KD, et al.
Published: (2020) -
Endpoint security /
by: 215290 Kadrich, Mark
Published: (2007) -
Biomarkers and surrogate endpoints.
by: Aronson, J
Published: (2005) -
Allograft function as endpoint for clinical trials in kidney transplantation
by: Hilbrands, L, et al.
Published: (2022)